| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
45,626 |
15,340 |
$1.99M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
25,722 |
9,996 |
$527K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40,355 |
13,706 |
$299K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,543 |
2,477 |
$99K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,103 |
1,831 |
$83K |
| 81418 |
|
35 |
30 |
$599.22 |
| 81226 |
|
18 |
13 |
$360.73 |
| 81225 |
|
18 |
13 |
$233.09 |
| 81227 |
|
18 |
13 |
$139.85 |
| 81401 |
|
18 |
13 |
$109.60 |
| 81241 |
|
18 |
13 |
$58.70 |
| 81240 |
|
18 |
13 |
$52.55 |
| 81291 |
|
18 |
13 |
$52.27 |
| 81355 |
|
18 |
13 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
63 |
40 |
$0.00 |
| 81328 |
|
18 |
13 |
$0.00 |
| 81230 |
|
18 |
13 |
$0.00 |
| 81231 |
|
18 |
13 |
$0.00 |